NIFTY| NSE | BSE | SENSEX | STOCK |MARKET LIVE |SHARE MARKET LIVE |INDIAN STOCK LIVE |NIFTY LIVE | UPDATES JULY 21 2020 | Chronicleplanet.com

Chronicleplanet.com

Best Latest News Provider

NIFTY| NSE | BSE | SENSEX | STOCK |MARKET LIVE |SHARE MARKET LIVE |INDIAN STOCK LIVE |NIFTY LIVE | UPDATES JULY 21 2020

3 min read

NIFTY| NSE | BSE | SENSEX |INDIAN STOCK LIVE |NIFTY LIVE | UPDATES JULY 21 2020

Sensex and Nifty opened on a bullish note on Tuesday, amid buoyed global equities. SGX Nifty was rising 100 points higher at 10,690, indicating positive trend in domestic grounds today. Sensex traded 389 points higher at 37,808 and Nifty was rising 114 points to 11,137. Yesterday, Sensex rose 398 points to 37,418 and Nifty ended 120 points higher to 11,022. Global equities were buoyed today amid first successful human trials of COVID-19 vaccine developed by the University of Oxford and hopes of economic stimulus from global central banks that boosted investor sentiment and increased their risk appetite. In India, AIIMS-Delhi also began recruiting volunteers for conducting human clinical trials of the indigenously developed COVID-19 vaccine candidate Covaxin. Meanwhile, Axis bank, Bajaj FinservBajaj Finance, CRISIL, DCM Shriram, HDFC Life, HUL, Hindustan Zinc, ICICI Pru life, SBI Life, SML Isuzu are among the top companies that will be reporting their April-June quarterly earnings.

Sensex, Nifty Updates: Sensex and Nifty opened on a bullish note on Tuesday, amid buoyed global equities. SGX Nifty was rising 100 points higher at 10,690, indicating positive trend in domestic grounds today. Sensex traded 389 points higher at 37,808 and Nifty was rising 114 points to 11,137. Yesterday, Sensex rose 398 points to 37,418 and Nifty ended 120 points higher to 11,022. Global equities were buoyed today amid first successful human trials of COVID-19 vaccine developed by the University of Oxford and hopes of economic stimulus from global central banks that boosted investor sentiment and increased their risk appetite. In India, AIIMS-Delhi also began recruiting volunteers for conducting human clinical trials of the indigenously developed COVID-19 vaccine candidate Covaxin. Meanwhile, Axis bank, Bajaj FinservBajaj Finance, CRISIL, DCM Shriram, HDFC Life, HUL, Hindustan Zinc, ICICI Pru life, SBI Life, SML Isuzu are among the top companies that will be reporting their April-June quarterly earnings.

Here’s a look at the updates of the market action on BSE and NSE today

Stocks to watch today on July 21

IndiGo, SBI Cards, ACC, Indian Oil, Jubilant Life among others are the top stocks to watch out for in Tuesday’s trading session.

Stocks in news: IndiGo, SBI Cards, ACC, Indian Oil, Jubilant Life

 Q1 Earnings scheduled for today

Axis bank, Bajaj Finserv, Bajaj Finance, CRISIL, DCM Shriram, HDFC Life, HUL, Hindustan Zinc, ICICI Pru life, SBI Life, SML Isuzu are among the top companies that will be reporting their April-June quarterly earnings.

Commenting over the outlook for real estate sector, Manoj Gaur, MD, Gaurs Group & Chairman, Affordable Housing Committee, CREDAI (National) said, “Coming year is crucial for the real estate sector which has been demanding for a relief package from the government to overcome the COVID-19 impact. Demand-wise the sector is well placed as people are seeking real estate assets like never before. People have realized the importance of owning a property as they have seen many investment vehicles go down during the last few months. The safety of the real estate investment has dawned on people, and this has made them seek out properties that fit their budget. Commercial will see an increased participation from people, who want to have an additional option of income.”

Gaur noted that his company booked 700 units valued at around Rs 225 crore during lockdown (March 25 onwards) with around 70-75% being residential and the rest commercial.

 Quote on SBI Cards 1QFY21 results

Commenting on 1QFY21 result of SBI Cards, Jaikishan Parmar, Sr. Equity Research Analyst, Angel Broking said,”SBI Cards reported an overall good set of numbers for Q1FY21. When lockdown begun investors were concerned about asset quality issues, however, SBI cards positivity surprised by reporting a very low number of the moratorium. Moratorium % to loan book declined from 29% in Q4FY20 to 6.7% in Q1FY21. Its active credit cards increased by 20% despite the lockdown. NIM Improved 260bps QoQ/414bps YoY as SBI card able to reduce the cost of fund and able increase yield on loan book. Total income declined by 5% YoY, primarily driven by plunge in other income 82% YoY. Controlled operating expenses helped cost to income ration to improve by 635bps to 47.2%. And finally, the Lower tax rate of the new regime helped SBI card to report PAT growth of 14% YoY.”